← Leaderboards
Vsevolod Katritch
Plexus Vaccine
$6,299,280
Attributed
$14,429,223
Total exposure
15
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,429,223 · 15
By mechanism
R01$5,456,358 · 4
UH3$1,940,013 · 1
U01$1,480,275 · 1
R61$1,325,500 · 1
UG3$1,302,218 · 2
R21$860,842 · 2
Top collaborators
- Vadim Cherezov12 shared
- Susruta Majumdar9 shared
- Bryan L Roth5 shared
- Andrew John Shepherd5 shared
- Tao Che3 shared
- Alexandros Makriyannis3 shared
- Jay P Mclaughlin3 shared
- Laura M Bohn2 shared
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructurePropertyLigandsReceptorScreeningIn VivoLeadPharmaceutical PreparationsDesignCollaborationsComplexAddictionAnalogSignal TransductionPainBindingIn VitroResolutionOpioidPain ManagementPharmacologyBaseGenerationsTechnology
Grant awards (30)
Drug Development for Alzheimer's neuroinflammation$1,480,275
U01 · FY2025 · AG
Development of Angiotensin AT2 inhibitors for neuropathic pain relief$818,360
UG3 · FY2025 · NS · contact PI
Targeting the allosteric sodium site with novel probes for delta opioid receptor$656,556
R01 · FY2025 · DA
Computational approaches to discover ligands with new chemotypes and functional properties$415,000
R35 · FY2025 · GM · contact PI
Development of PAC1 receptor antagonists for the treatment of Headache Disorders$1,325,500
R61 · FY2024 · NS
Targeting the allosteric sodium site with novel probes for delta opioid receptor$664,982
R01 · FY2024 · DA
Efficient synthon-based modular screening of Giga-to-Terra-scale virtual libraries$412,500
R01 · FY2024 · GM · contact PI
Computational approaches to discover ligands with new chemotypes and functional properties$69,167
R35 · FY2024 · GM · contact PI
Targeting the allosteric sodium site with novel probes for delta opioid receptor$653,137
R01 · FY2023 · DA
Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief$607,440
UH3 · FY2023 · NS · contact PI
Efficient synthon-based modular screening of Giga-to-Terra-scale virtual libraries$412,500
R01 · FY2023 · GM · contact PI
Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief$647,556
UH3 · FY2022 · NS · contact PI
Efficient synthon-based modular screening of Giga-to-Terra-scale virtual libraries$412,500
R01 · FY2022 · GM · contact PI
Structure and Function of CB2 Receptor$763,601
R01 · FY2021 · DA
Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief$685,017
UH3 · FY2021 · NS · contact PI
Structure and Function of CB2 Receptor$763,601
R01 · FY2020 · DA
Structure Function of CB1 Cannabinoid Receptor$716,981
R01 · FY2020 · DA · contact PI
Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief$483,858
UG3 · FY2020 · NS · contact PI
Rational discovery of new DOR chemotypes to prevent addiction and overdose$355,641
R33 · FY2018 · DA · contact PI
Structure-Based Discovery Opioid Receptor Ligands and Molecules, p. 83$148,996
P01 · FY2018 · DA · contact PI
Rational discovery of new DOR chemotypes to prevent addiction and overdose$362,942
R33 · FY2017 · DA · contact PI
Structure guided design of photoselectable channelrhodopsins$219,593
R21 · FY2017 · EY
Structure-Based Discovery Opioid Receptor Ligands and Molecules, p. 83$148,996
P01 · FY2017 · DA · contact PI
Structure guided design of photoselectable channelrhodopsins$230,968
R21 · FY2016 · EY
Rational discovery of new DOR chemotypes to prevent addiction and overdose$204,187
R21 · FY2016 · DA · contact PI
Structure-Based Discovery Opioid Receptor Ligands and Molecules, p. 83$147,505
P01 · FY2016 · DA · contact PI
Rational discovery of new DOR chemotypes to prevent addiction and overdose$206,094
R21 · FY2015 · DA · contact PI
Structure-Based Discovery Opioid Receptor Ligands and Molecules, p. 83$146,651
P01 · FY2015 · DA · contact PI
Structure-Based Discovery Opioid Receptor Ligands and Molecules, p. 83$171,119
P01 · FY2014 · DA · contact PI
Rational Anthrax Vaccine with Structural Epitopes on VLP$98,000
R43 · FY2002 · AI